検索結果 1969 件
フルテキストURL | fulltext.pdf |
---|---|
著者 | Takahashi, Yuko| Iwamoto, Takayuki| Suzuki, Yoko| Kajiwara, Yukiko| Hatono, Minami| Tsukioki, Takahiro| Kawada, Kengo| Kochi, Mariko| Ikeda, Hirokuni| Shien, Tadahiko| Taira, Naruto| Matsuoka, Junji| Doihara, Hiroyoshi| Toyooka, Shinichi| |
キーワード | Gene expression Hormone receptor positive Residual tumor burden Targeted therapy Triple negative |
発行日 | 2020-04 |
出版物タイトル | Clinical Breast Cancer |
巻 | 20巻 |
号 | 2号 |
出版者 | Elsevier |
開始ページ | 117 |
終了ページ | 124 |
ISSN | 1526-8209 |
NCID | AA11694891 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
論文のバージョン | author |
PubMed ID | 31570267 |
DOI | 10.1016/j.clbc.2019.07.001 |
Web of Science KeyUT | 000529805200021 |
関連URL | isVersionOf https://doi.org/10.1016/j.clbc.2019.07.001 |
フルテキストURL | K0006014_abstract_review.pdf K0006014_summary.pdf K0006014_fulltext.pdf |
---|---|
著者 | 山本 晃| |
発行日 | 2019-06-30 |
資料タイプ | 学位論文 |
学位授与番号 | 甲第6014号 |
学位授与年月日 | 2019-06-30 |
学位・専攻分野 | 博士(医学) |
授与大学 | 岡山大学 |
言語 | 英語 |
JaLCDOI | 10.18926/AMO/56940 |
---|---|
フルテキストURL | 73_4_367.pdf |
著者 | Mifune-Morioka, Tomoyo| A. Uchida, Haruhito| Fukushima, Kazuhiko| Watanabe, Mayu| Ouchi, Chihiro| Mise, Koki| Kawakita, Chieko| Kano, Yuzuki| Onishi, Akifumi| Toma, Kishio| Eguchi, Jun| Wada, Nozomu| Ikeda, Fusao| Sasaki, Erika| Suganami, Yu| Kishida, Masayuki| Sugiyama, Hitoshi| Okada, Hiroyuki| Wada, Jun| |
抄録 | Eight years prior to her present admission, a 61-year-old Japanese woman was diagnosed with autoimmune hepatitis, slowly progressive insulin-dependent diabetes mellitus, and chronic thyroiditis; she had been treated with oral prednisolone (PSL). After she suddenly discontinued PSL, she newly developed systemic lupus erythematosus. A combination therapy of oral PSL and intravenous cyclophosphamide resulted in remission. She was finally diagnosed with autoimmune polyglandular syndrome (APS) type 3 (3A ,3B, 3D), complicated with four different autoimmune diseases. Since patients with type 3 APS may present many manifestations over a long period of time, they should be carefully monitored. |
キーワード | autoimmune polyglandular syndrome type 3 systemic lupus erythematosus autoimmune hepatitis slowly progressive insulin-dependent diabetes mellitus chronic thyroiditis |
Amo Type | Case Report |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-08 |
巻 | 73巻 |
号 | 4号 |
出版者 | Okayama University Medical School |
開始ページ | 367 |
終了ページ | 372 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 31439961 |
JaLCDOI | 10.18926/AMO/56931 |
---|---|
フルテキストURL | 73_4_299.pdf |
著者 | Hiranaka, Takaaki| Nishida, Keiichiro| Konishiike, Taizo| Ozaki, Toshifumi| Mikasa, Motohiko| |
抄録 | The fixation technique of bony fragments is crucial for the bone union of the tuberosities after humeral head replacement (HHR) for a comminuted fracture of the proximal humerus. To increase the bone union rate, we reduce tuberosities to overlap on the humeral shaft by approx. 1 cm and fix them with cable wire. Herein, we retrospectively investigated the clinical and radiographic outcomes of our procedure. Twenty-six patients who underwent cementless HHR for the treatment of comminuted fractures of the proximal humerus were investigated. The Constant-Murley score, active shoulder mobility, and bone union rate were evaluated. The mean duration of follow-up was 56.3 months (range 24-197). At the final follow-up, the average Constant-Murley score was 58 (range 40-76). Forward elevation was 126° on average (range 35°-180°). Twenty-three cases (88%) showed bone union between the tuberosities and the shaft at an average follow-up of 4.1 months (range 4-5 months) after surgery. Non-union was noted in 1 case, and bone resorption was noted in 2 cases. The bone union rate and the clinical outcome of our procedure were relatively favorable |
キーワード | humeral head replacement tuberosity-overlapping technique bone union of tuberosities cable wire cementless stem |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-08 |
巻 | 73巻 |
号 | 4号 |
出版者 | Okayama University Medical School |
開始ページ | 299 |
終了ページ | 305 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 31439952 |
JaLCDOI | 10.18926/AMO/56930 |
---|---|
フルテキストURL | 73_4_285.pdf |
著者 | Otani, Yoshihiro| Ichikawa, Tomotsugu| Kurozumi, Kazuhiko| Date, Isao| |
抄録 | Gliomas are characterized as highly diffuse infiltrating tumors, and currently available treatments such as surgery, radiation and chemotherapy are unfeasible or show limited efficacy against these tumors. Recent genetic and epigenetic analyses of glioma have revealed increasing evidence of the role of driver genetic alterations in glioma development and led to the identification of prognostic factors. Despite these findings, the survival rates of glioma patients remain low, and alternative treatments and novel targets are needed. Recent studies identified neural stem cells as the possible origin of gliomas, and some evidence has revealed shared functions and mechanisms between glioma cells and neurons, also supporting their similarity. The cytoskeleton plays important roles in the migration of normal cells as well as cancer cells. Recent reports have described a role for microtubules, a component of the cytoskeleton, in glioma invasion. Notably, several factors that regulate microtubule functions, such as microtubule-associated proteins, plus-end tracking proteins, or motor proteins, are upregulated in glioma tissues compared with normal tissue, and upregulation of these factors is associated with high invasiveness of glioma cells. In this review, we describe the mechanism of microtubules in glioma invasion and discuss the possibility of microtubule-targeted therapy to inhibit glioma invasion. |
キーワード | glioma cytoskeletons invasion microtubules |
Amo Type | Review |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-08 |
巻 | 73巻 |
号 | 4号 |
出版者 | Okayama University Medical School |
開始ページ | 285 |
終了ページ | 297 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 31439951 |
JaLCDOI | 10.18926/AMO/56873 |
---|---|
フルテキストURL | 73_3_279.pdf |
著者 | Makimoto, Go| Nishimori, Hisakazu| Kondo, Reiko| Yanai, Hiroyuki| Sugimoto, Morito| Oda, Naohiro| Kubo, Toshio| Hotta, Katsuyuki| Tabata, Masahiro| Kiura, Katsuyuki| Maeda, Yoshinobu| |
抄録 | Urothelial carcinoma usually presents with hematuria, but cases of multiple lymphadenopathy with elevated S-pancreas-1 antigen (SPan-1) levels have not been reported. A 62-year-old Japanese man with lymphadenopathies was diagnosed with an adenocarcinoma of unknown origin and transferred to our hospital for further diagnosis. Serum carbohydrate antigen 19-9 and SPan-1 levels were extremely elevated. Uroplakin III immunostaining was positive in the inguinal lymph node, and cystoscopy revealed the presence of invasive urothelial carcinoma. Treatment with cisplatin and gemcitabine promoted a complete metabolic response for > 4 years. The detection of uroplakin III and serum SPan-1 might help diagnose urothelial carcinoma. |
キーワード | urothelial carcinoma uroplakin III s-pancreas-1 antigen carbohydrate antigen 19-9 chemotherapy |
Amo Type | Case Report |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-06 |
巻 | 73巻 |
号 | 3号 |
出版者 | Okayama University Medical School |
開始ページ | 279 |
終了ページ | 284 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 31235978 |
JaLCDOI | 10.18926/AMO/56869 |
---|---|
フルテキストURL | 73_3_255.pdf |
著者 | Seki, Daisuke| Takeshita, Nobuo| Seiryu, Masahiro| Deguchi, Toru| Takano-Yamamoto, Teruko| |
抄録 | Orthodontists need to understand the orthodontic risks associated with systemic disorders. Axenfeld-Rieger syndrome (ARS) is a rare autosomal dominant disorder with genetic and morphological variability. The risks of orthodontic treatment in ARS patients have been unclear. Here we describe the correction of an anterior open bite in a 15-year-old Japanese female ARS patient by molar intrusion using sectional archwires with miniscrew implants. An undesirable development of external apical root resorption (EARR) was observed in all intrusive force-applied posterior teeth during the patient’s orthodontic treatment, suggesting that ARS patients have a higher risk of EARR than the general population. |
キーワード | Axenfeld-Rieger syndrome external apical root resorption miniscrew implant anterior open bite |
Amo Type | Case Report |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-06 |
巻 | 73巻 |
号 | 3号 |
出版者 | Okayama University Medical School |
開始ページ | 255 |
終了ページ | 262 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 31235974 |
JaLCDOI | 10.18926/AMO/56868 |
---|---|
フルテキストURL | 73_3_247.pdf |
著者 | Yoshio, Kotaro| Wakita, Akihisa| Mitsuhashi, Toshiharu| Kitayama, Takahiro| Hisazumi, Kento| Inoue, Daisaku| Tajiri, Nobuhisa| Shiode, Tsuyoki| Akaki, Shiro| Kanazawa, Susumu| |
抄録 | We investigated the feasibility of simultaneous integrated boost (SIB) volumetric modulated arc therapy (VMAT) using elective nodal irradiation (ENI) for middle or lower esophageal cancer and compared it with three-dimensional conformal radiotherapy (3D-CRT). The study included 15 patients. The prescribed doses included a standard dose (50.4 Gy) and a high dose (60 Gy) for the planning target volume (PTV) of the involved lesions. The objective of the whole lung volume receiving ≥ 20 Gy (V20Gy) was < 30%, and the mean lung dose (MLD) was < 20 Gy. The volumes of the lung receiving 5 Gy (V5Gy) and the heart receiving 30-50 Gy (V30-50Gy) were kept as low as reasonably achievable. As a result, SIB-VMAT showed superior dose conformity for the PTV (p<0.001). Although the lung V5Gy was significantly increased (p<0.001), the V20Gy and MLD showed no significant increase. The heart V30-50Gy showed a > 20% reduction in the mean against 3D-CRTs. Our results demonstrate the feasibility of SIB-VMAT for the treatment of middle or lower esophageal cancer with ENI. Although attention should be paid to the low-dose area of the lungs, SIB-VMAT would be a promising treatment option with improved outcomes for esophageal cancer. |
キーワード | esophageal cancer middle and lower thoracic volumetric modulated arc therapy, 3D-CRT elective nodal irradiation |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-06 |
巻 | 73巻 |
号 | 3号 |
出版者 | Okayama University Medical School |
開始ページ | 247 |
終了ページ | 257 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 31235973 |
フルテキストURL | Tissue_Eng_A_2018_0348.pdf |
---|---|
著者 | Sogawa, Chiharu| Eguchi, Takanori| Okusha, Yuka| Ono, Kisho| Ohyama, Kazumi| Iizuka, Motoharu| Kawasaki, Ryu| Hamada, Yusaku| Takigawa, Masaharu| Sogawa, Norio| Okamoto, Kuniaki| Kozaki , Ken-ichi| |
キーワード | 3D tumoroid reporter assay Wnt/β-catenin signaling cancer metastasis metalloproteinase syngeneic transplantation tumoroid (tumor organoid) |
備考 | This is an Accepted Manuscript of an article published by Mary Ann Liebert| |
発行日 | 2019-02-08 |
出版物タイトル | Tissue Engineering Part A. |
巻 | 25巻 |
号 | 19-20号 |
出版者 | Mary Ann Liebert |
開始ページ | 1413 |
終了ページ | 1425 |
ISSN | 19373341 |
NCID | AA12306003 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
論文のバージョン | author |
PubMed ID | 30734664 |
DOI | 10.1089/ten.TEA.2018.0348 |
NAID | 120006788780 |
Web of Science KeyUT | 000489035900008 |
関連URL | isVersionOf https://doi.org/10.1089/ten.TEA.2018.0348 |
フルテキストURL | K0005969_abstract_review.pdf K0005969_summary.pdf K0005969_fulltext.pdf |
---|---|
著者 | 中島 芳樹| |
発行日 | 2019-03-25 |
資料タイプ | 学位論文 |
学位授与番号 | 甲第5969号 |
学位授与年月日 | 2019-03-25 |
学位・専攻分野 | 博士(理学) |
授与大学 | 岡山大学 |
言語 | 英語 |
フルテキストURL | K0005881_abstract_review.pdf K0005881_summary.pdf K0005881_fulltext.pdf |
---|---|
著者 | 今井 大誉| |
発行日 | 2019-03-25 |
資料タイプ | 学位論文 |
学位授与番号 | 甲第5881号 |
学位授与年月日 | 2019-03-25 |
学位・専攻分野 | 博士(医学) |
授与大学 | 岡山大学 |
言語 | 英語 |
フルテキストURL | Plos_Negl_Trop_Dis_5386.pdf |
---|---|
著者 | Imamura, Daisuke| Morita, Masatomo| Sekizuka, Tsuyoshi| Mizuno, Tamaki| Takemura, Taichiro| Yamashiro, Tetsu| Chowdhury, Goutam| Pazhani, Gururaja P.| Mukhopadhyay, Asish K.| Ramamurthy, Thandavarayan| Miyoshi, Shin-ichi| Kuroda, Makoto| Shinoda, Sumio| Ohnishi, Makoto| |
備考 | This research is supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from Ministry of Education, Culture, Sport, Science & Technology in Japan, and Japan Agency for Medical Research and Development (AMED).| |
発行日 | 2017-02-13 |
出版物タイトル | PLOS Neglected Tropical Diseases |
巻 | 11巻 |
号 | 2号 |
出版者 | PLOS |
開始ページ | e0005386 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
論文のバージョン | publisher |
PubMed ID | 28192431 |
DOI | 10.1371/journal.pntd.0005386 |
Web of Science KeyUT | 000396406600020 |
関連URL | isVersionOf https://doi.org/10.1371/journal.pntd.0005386 |
JaLCDOI | 10.18926/AMO/56655 |
---|---|
フルテキストURL | 73_2_181.pdf |
著者 | Okamura, Tomoka| Washio, Yousuke| Yoshimoto, Junko| Tani, Kazumasa| Tsukahara, Hirokazu| Shimada, Akira| |
抄録 | Most cases of transient abnormal myelopoiesis (TAM) in neonates with Down syndrome (DS) resolve spontaneously; however, DS-TAM neonates with hydrops fetalis (HF) show poor clinical outcomes. We report three infants with DS-TAM and HF who were treated with exchange transfusion (ET) followed by low-dose cytarabine (LD-CA). All of them survived without developing liver failure, acute leukemia, or other serious adverse events. Our results suggest that this combination treatment with ET and LD-CA would be safe, tolerable and effective as an novel approach for DS-TAM patients with HF. |
キーワード | cytarabine Down syndrome exchange transfusion hydrops fetalis transient abnormal myelopoiesis |
Amo Type | Case Report |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-04 |
巻 | 73巻 |
号 | 2号 |
出版者 | Okayama University Medical School |
開始ページ | 181 |
終了ページ | 188 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 31015754 |
JaLCDOI | 10.18926/AMO/56652 |
---|---|
フルテキストURL | 73_2_161.pdf |
著者 | Okamoto, Sachiyo| Matsuoka, Ken-ichi| Sakamoto, Maiko| Usui, Yoshiaki| Fujiwara, Yuki| Kondo, Takumi| Tani, Katsuma| Saeki, Kyosuke| Meguri, Yusuke| Asada, Noboru| Ennishi, Daisuke| Nishimori, Hisakazu| Fujii, Keiko| Fujii, Nobuharu| Maeda, Yoshinobu| |
抄録 | Second allogeneic stem cell transplantation (allo-SCT) is a potentially curative therapy for patients who relapse after first allo-SCT. Human leukocyte antigen (HLA)-haploidentical related donors provide the broad opportunity to conduct second SCT at the appropriate time, but the efficacy of second SCT from haploidentical donors after relapse has not been established. We retrospectively analyzed the records of 33 patients who underwent second SCT. Twenty patients underwent haplo-SCT with low-dose antithymocyte globulin (ATG), and the other 13 patients underwent conventional- SCTs, including HLA-matched related peripheral blood, unrelated bone marrow or cord blood. Three years after the second SCT, the overall survival (OS) and progression-free survival (PFS) of all patients were 32.5% and 23.9%. Multivariate analyses indicated that non-complete response at second SCT, less than 1-year interval to relapse after first- SCT, and total score ≥ 3 on the hematopoietic cell transplantation-specific comorbidity index were significantly associated with a lower PFS rate. The haplo- and conventional- SCT groups showed equivalent results regarding OS, PFS, cumulative incidences of relapse, non-relapse mortality and graft-versus-host disease. The neutropenic period after transplantation was significantly shorter in haplo- SCT than conventional- SCT (10.5 days vs. 16 days, p=0.001). Our analysis revealed that haplo-SCT could be an alternative therapeutic option for relapsed patients after first SCT. |
キーワード | allogeneic stem cell transplantation haploidentical stem cell transplantation relapse anti-T lymphocyte globulin |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-04 |
巻 | 73巻 |
号 | 2号 |
出版者 | Okayama University Medical School |
開始ページ | 161 |
終了ページ | 171 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 31015751 |
JaLCDOI | 10.18926/AMO/56650 |
---|---|
フルテキストURL | 73_2_147.pdf |
著者 | Hayashi, Masao| Taniguchi, Arata| Kaku, Ryuji| Fujimoto, Shusaku| Isoyama, Satoshi| Manabe, Sei| Yoshida, Tsubasa| Suzuki, Satoshi| Shimizu, Kazuyoshi| Morimatsu, Hiroshi| Momota, Ryusuke| |
抄録 | Tachycardia is common in intensive care units (ICUs). It is unknown whether tachycardia or prolonged tachycardia affects patient outcomes. We investigated the association between tachycardia and mortality in critically ill patients. This retrospective cohort study’s primary outcome was patient mortality in the ICU and the hospital. We stratified the patients (n=476) by heart rate (HR) as LowHR, MediumHR, and HighHR groups. We also stratified them by their durations of HR >100 (prolonged HR; tachycardia): MildT, ModerateT, and SevereT groups. We determined the six groups’ mortality. The ICU mortality rates of the LowHR, MediumHR, and HighHR groups were 1.0%, 1.5%, and 7.9%, respectively; significantly higher in the HighHR vs. LowHR group. The in-hospital mortality rates of these groups were 1%, 4.5%, and 14.6%, respectively; significantly higher in the HighHR vs. LowHR group. The ICU mortality rates of the MildT, ModerateT, and SevereT groups were 0.9%, 5.6%, and 57.1%, respectively. The mortality of the HRT=0 (i.e., all HR ≤ 100) patients was 0%. The in-hospital mortality rates of the MildT, ModerateT, and SevereT groups were 1.8%, 16.7%, and 85.7%, respectively; that of the HRT=0 patients was 0.5%. Both higher HR and prolonged tachycardia were associated with poor outcomes. |
キーワード | tachycardia mortality ICU in-hospital |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-04 |
巻 | 73巻 |
号 | 2号 |
出版者 | Okayama University Medical School |
開始ページ | 147 |
終了ページ | 153 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 31015749 |
JaLCDOI | 10.18926/AMO/56646 |
---|---|
フルテキストURL | 73_2_109.pdf |
著者 | Abe, Makoto| Iwamuro, Masaya| Kawahara, Yoshiro| Kanzaki, Hiromitsu| Kawano, Seiji| Tanaka, Takehiro| Tsumura, Munechika| Makino, Takuma| Noda, Yohei| Marunaka, Hidenori| Nishizaki, Kazunori| Okada, Hiroyuki| |
抄録 | The efficacy and safety of endoscopic submucosal dissection (ESD) for superficial cancer of the pharynx are still unclear. To identify clinicopathological features of superficial pharyngeal cancer, and the efficacy and safety of ESD, we retrospectively assessed 70 pharyngeal cancers in 59 patients who underwent ESD. Of these patients, 61.0% and 50.8% had a history of esophageal cancer and head and neck cancer, respectively. The median tumor size was 15 mm, and 75.7% of the lesions were located at the piriform sinus. The en bloc resection rate was 94.9%. Treatment-related adverse events occurred in 8 cases, but there was no treatment-related death. The lateral margin was positive for neoplasm in 3 lesions (4.3%) and inconclusive in 27 lesions (38.6%), but no local recurrence was observed. Cervical lymph node metastasis was observed in 6 patients, and was successfully treated by cervical lymph node dissection. The three-year overall survival rate was 91.5% (95%CI: 76.6-97.3%) and the cause-specific survival rate was 97.6% (95%CI: 84.9-99.7%). In conclusion, ESD for superficial pharyngeal cancer was safe and effective. “Resect and watch” is probably a feasible and rational strategy for treatment of patients with superficial pharyngeal cancer. |
キーワード | endoscopic submucosal dissection superficial cancer pharynx endoscopic resection |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-04 |
巻 | 73巻 |
号 | 2号 |
出版者 | Okayama University Medical School |
開始ページ | 109 |
終了ページ | 115 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 31015745 |
JaLCDOI | 10.18926/AMO/56458 |
---|---|
フルテキストURL | 73_1_51.pdf |
著者 | Fujii, Masakuni| Fujimoto, Kenji| Yabe, Syuntaro| Nasu, Junichiro| Miyaike, Jiro| Yoshioka, Masao| Shiode, Junji| Yamamoto, Kazuhide| Matsuda, Shinya| |
抄録 | We investigated the relationship between body mass index (BMI) and postoperative outcomes in 450 gallbladder cancer patients in Japan. We collected patient information, including sex, age, underlying disease, BMI, stage, surgery method, postoperative time to discharge, and postoperative Medicare fees, from the Japanese administrative database associated with the Diagnosis Procedure Combination system. We classified patient BMIs as underweight (BMI<18.5 kg/m2), normal (BMI≥18.5 kg/m2 and <25 kg/m2) or overweight/obese (BMI≥25 kg/m2), then investigated the relationship between these categories and two postoperative outcomes: time to discharge and postoperative Medicare fees. The median postoperative time to discharge was 12 days in all patients, and 12 days in each of the three weight groups (p=0.62, n.s.). The median postoperative Medicare fees from surgery until discharge were (USD): all patients, $5,002; underweight, $5,875; normal weight, $4,797; and overweight/obese, $5,179 (p=0.146, n.s.). A multivariate analysis with adjustment for competing risk factors revealed that BMI was not associated with increased risk of longer postoperative time to discharge (normal weight: HR 1.17, p=0.29; overweight/obese: HR 1.17, p=0.37) or higher postoperative Medicare fees (OR 0.99, p=0.86, n.s.). Thus, high BMI was not found to be a factor for poor postoperative outcomes in Japanese patients with gallbladder cancer. |
キーワード | body mass index gallbladder cancer surgery obesity |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2019-02 |
巻 | 73巻 |
号 | 1号 |
出版者 | Okayama University Medical School |
開始ページ | 51 |
終了ページ | 59 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2019 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 30820054 |
JaLCDOI | 10.18926/AMO/56248 |
---|---|
フルテキストURL | 72_5_499.pdf |
著者 | Kodama, Yuya| Furumatsu, Takayuki| Maehara, Ami| Ozaki, Toshifumi| |
抄録 | Cell clusters, or groups of cells sharing a single chondron-like structure, are frequently found in degenerated areas of the osteoarthritic (OA) meniscus. However, little is known about these meniscal clusters in humans. The aim of our study was to determine the composition of the extracellular matrix deposition around cell clusters in human OA menisci. Twenty-six menisci were obtained through total knee arthroplasty from patients with OA knee joints. The specimens were subjected to safranin O staining and immunostaining for Sry-type HMG box 9 (SOX9), type II collagen, and aggrecan. Their signal density after staining was assessed using ImageJ software. Five regions of interest were analyzed within each tissue sample. The SOX9, type II collagen, and aggrecan densities were considerably higher in cluster areas than in intact superficial layers of the meniscus. In addition, a substantial difference was detected between cluster areas and degenerative areas without cell clusters. We demonstrated that cell clusters localized near fissures and clefts showed remarkable uniformity in menisci exposed to a broad range of injuries. In addition, the chondrogenic proteins SOX9, type II collagen, and aggrecan were highly expressed in these tissues. |
キーワード | cell cluster meniscus osteoarthritis Sry-type HMG box 9 type II collagen |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2018-10 |
巻 | 72巻 |
号 | 5号 |
出版者 | Okayama University Medical School |
開始ページ | 499 |
終了ページ | 506 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2018 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 30369607 |
フルテキストURL | bfsc_039_001_007.pdf |
---|---|
著者 | 岡山大学農学部附属山陽圏フィールド科学センター | |
出版物タイトル | 岡山大学農学部センター報告 |
発行日 | 2017-04-01 |
巻 | 39巻 |
開始ページ | 1 |
終了ページ | 7 |
ISSN | 0910-8742 |
言語 | 日本語 |
著作権者 | 岡山大学農学部 |
論文のバージョン | publisher |
フルテキストURL | PhysRevB_97_094505.pdf |
---|---|
著者 | Terao, Takahiro| Yang, Xiaofan| Miao, Xiao| Zheng, Lu| Goto, Hidenori| Miyazaki, Takafumi| Yamaoka, Hitoshi| Ishii, Hirofumi| Liao, Yen-Fa| Kubozono, Yoshihiro| |
キーワード | Superconductors 2-dimensional systems 4-terminal techniques Pressure effects X-ray diffraction |
備考 | This is an article published by American Physical Society| This study was partly supported by Grants-in-Aid (26105004 and 26400361) from MEXT, by JST ACT-C Grant No. JPMJCR12YW, Japan, and by the Program for Promoting the Enhancement of Research Universities.| |
発行日 | 2018-03-09 |
出版物タイトル | Physical Review B |
巻 | 97巻 |
号 | 9号 |
出版者 | American Physical Society |
開始ページ | 094505 |
ISSN | 01631829 |
NCID | AA11187113 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
論文のバージョン | publisher |
DOI | 10.1103/PhysRevB.97.094505 |
Web of Science KeyUT | 000427010000003 |
関連URL | isVersionOf https://doi.org/10.1103/PhysRevB.97.094505 |